BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scharf C, Liebchen U, Paal M, Becker-Pennrich A, Irlbeck M, Zoller M, Schroeder I. Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot study. Sci Rep 2021;11:10190. [PMID: 33986443 DOI: 10.1038/s41598-021-89712-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ocskay K, Tomescu D, Faltlhauser A, Jacob D, Friesecke S, Malbrain M, Kogelmann K, Bogdanski R, Bach F, Fritz H, Hartjes A, Kortgen A, Soukup J, Utzolino S, van Tellingen M, Träger K, Schumacher U, Brunkhorst FM, Molnar Z. Hemoadsorption in 'Liver Indication'-Analysis of 109 Patients' Data from the CytoSorb International Registry. J Clin Med 2021;10:5182. [PMID: 34768702 DOI: 10.3390/jcm10215182] [Reference Citation Analysis]
2 Köhler T, Schwier E, Praxenthaler J, Kirchner C, Henzler D, Eickmeyer C. Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb®-Basics, Indications and Perspectives-A Scoping Review. Int J Mol Sci 2021;22:12786. [PMID: 34884590 DOI: 10.3390/ijms222312786] [Reference Citation Analysis]
3 Hui WF, Lun KS, Hon KL. Single-pass albumin dialysis and hemoadsorption for bilirubin and bile acids removal for a child with hyperbilirubinemia after ventricular assist device implantation. J Artif Organs 2022. [PMID: 35038050 DOI: 10.1007/s10047-022-01309-4] [Reference Citation Analysis]
4 Ruiz-Rodríguez JC, Molnar Z, Deliargyris EN, Ferrer R. The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences. Crit Care Res Pract 2021;2021:7769516. [PMID: 34336280 DOI: 10.1155/2021/7769516] [Reference Citation Analysis]
5 Sekandarzad A, Weber E, Prager EP, Graf E, Bettinger D, Wengenmayer T, Supady A. Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)-a single center, open-label, three-arm, randomized, controlled intervention trial. Trials 2022;23:222. [PMID: 35303938 DOI: 10.1186/s13063-022-06139-6] [Reference Citation Analysis]
6 Tampe D, Korsten P, Bremer SCB, Winkler MS, Tampe B. Kinetics of Bilirubin and Ammonia Elimination during Hemadsorption Therapy in Secondary Sclerosing Cholangitis Following ECMO Therapy and Severe COVID-19. Biomedicines 2021;9:1841. [PMID: 34944657 DOI: 10.3390/biomedicines9121841] [Reference Citation Analysis]
7 Rachunek K, Krause M, Thiel JT, Kolbenschlag J, Daigeler A, Bury A. Technical Note: Novel Use of CytoSorb™ Haemadsorption to Provide Wound Healing Support in Case of Severe Burn Trauma via Reduction of Hyperbilirubinaemia. Front Surg 2021;8:743571. [PMID: 34977137 DOI: 10.3389/fsurg.2021.743571] [Reference Citation Analysis]
8 Acharya M, Berger R, Popov AF. The role of the ADVanced Organ Support (ADVOS) system in critically ill patients with multiple organ failure. Artif Organs 2022. [PMID: 35128695 DOI: 10.1111/aor.14188] [Reference Citation Analysis]